More recent studies have involved a targeted capture enriched for complement components that led to discovery of enrichment of rare variants in CFH in AMD patients [60] as well as the largest AMD GWAS study to date that examined >12 million variants in 16,144 patients and 17,832 controls [61]. Here, CFH is linked to age-related macular degeneration.